These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 33901321

  • 21. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J, Jing Z, Hu W, Yu J, Cui X.
    Med Sci Monit; 2017 Oct 24; 23():5056-5069. PubMed ID: 29061958
    [Abstract] [Full Text] [Related]

  • 22. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
    Yamaguchi M, Weitzmann MN, Murata T.
    Mol Cell Biochem; 2012 Jan 24; 359(1-2):193-203. PubMed ID: 21842421
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of RGS10 Aggravates Periapical Periodontitis via Upregulation of the NF-κB Pathway.
    Wei W, Li J, Liu X, Pan W, Wang M, Li J, Yue Y, Hao L.
    J Endod; 2022 Oct 24; 48(10):1308-1318.e5. PubMed ID: 36041584
    [Abstract] [Full Text] [Related]

  • 24. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 24; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 25. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB.
    Arthritis Rheum; 2010 Feb 24; 62(2):402-13. PubMed ID: 20112358
    [Abstract] [Full Text] [Related]

  • 26. Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide.
    Soysa NS, Alles N, Takahashi M, Aoki K, Ohya K.
    J Periodontal Res; 2011 Apr 24; 46(2):280-4. PubMed ID: 21348872
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.
    J Bone Miner Res; 2003 Dec 24; 18(12):2159-68. PubMed ID: 14672351
    [Abstract] [Full Text] [Related]

  • 31. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling.
    Henry KL, Kellner D, Bajrami B, Anderson JE, Beyna M, Bhisetti G, Cameron T, Capacci AG, Bertolotti-Ciarlet A, Feng J, Gao B, Hopkins B, Jenkins T, Li K, May-Dracka T, Murugan P, Wei R, Zeng W, Allaire N, Buckler A, Loh C, Juhasz P, Lucas B, Ennis KA, Vollman E, Cahir-McFarland E, Hett EC, Ols ML.
    Sci Signal; 2018 Jul 31; 11(541):. PubMed ID: 30065029
    [Abstract] [Full Text] [Related]

  • 32. HDAC5-Mediated Acetylation of p100 Suppresses Its Processing.
    Wang J, Wu S, Liu L, Pang Y, Li Z, Mu H.
    Int Dent J; 2023 Jun 31; 73(3):387-394. PubMed ID: 36156247
    [Abstract] [Full Text] [Related]

  • 33. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q, Luo A, Zhou Z, Xuan W, Qiu M, Wu Q, Xu L, Kong X, Zhang M, Tan W, Xue M, Wang F.
    Cytokine; 2019 Jan 31; 113():144-154. PubMed ID: 30001863
    [Abstract] [Full Text] [Related]

  • 34. G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-κB and MAPK signaling pathways.
    Park JW, Yoon HJ, Kang WY, Cho S, Seong SJ, Lee HW, Yoon YR, Kim HJ.
    J Cell Physiol; 2018 Feb 31; 233(2):1481-1489. PubMed ID: 28574596
    [Abstract] [Full Text] [Related]

  • 35. [NF-κB signaling pathways and the future perspectives of bone disease therapy using selective inhibitors of NF-κB].
    Jimi E, Fukushima H.
    Clin Calcium; 2016 Feb 31; 26(2):298-304. PubMed ID: 26813510
    [Abstract] [Full Text] [Related]

  • 36. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
    Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ.
    Sci Signal; 2014 Feb 04; 7(311):ra13. PubMed ID: 24497610
    [Abstract] [Full Text] [Related]

  • 37. Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells.
    Tsubaki M, Takeda T, Matsuda T, Yamamoto Y, Higashinaka A, Yamamoto K, Tsurushima K, Ishizaka T, Nishida S.
    Cytokine; 2021 Aug 04; 144():155591. PubMed ID: 34052656
    [Abstract] [Full Text] [Related]

  • 38. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
    Meng J, Zhou C, Zhang W, Wang W, He B, Hu B, Jiang G, Wang Y, Hong J, Li S, He J, Yan S, Yan W.
    J Cell Mol Med; 2019 Oct 04; 23(10):6730-6743. PubMed ID: 31328430
    [Abstract] [Full Text] [Related]

  • 39. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM, Lee DW, Jung JU, Sitcheran R.
    Mol Cancer; 2015 Jan 27; 14(1):9. PubMed ID: 25622756
    [Abstract] [Full Text] [Related]

  • 40. TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection.
    Hoffpauir CT, Bell SL, West KO, Jing T, Wagner AR, Torres-Odio S, Cox JS, West AP, Li P, Patrick KL, Watson RO.
    J Immunol; 2020 Jul 01; 205(1):153-167. PubMed ID: 32404352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.